Beyond medication: Understanding child and caregiver perspectives on multifaceted adherence in pediatric

Madeline Peek1, Kathryn Vannatta1,2, Misty Evans3,4

  • 1The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, USA.

Insights

This study explored adherence challenges for children after hematopoietic stem cell transplant (HCT). Findings highlight the need for family-centered strategies and clear communication to improve pediatric HCT care.

Area of Science:

  • Pediatric Hematology and Oncology
  • Adolescent Medicine
  • Qualitative Health Research

Background:

  • Hematopoietic stem cell transplant (HCT) is a complex treatment for pediatric cancers and other disorders.
  • Adherence to post-transplant medication regimens and lifestyle guidelines is critical for successful outcomes.
  • Understanding the unique challenges faced by pediatric HCT patients and their families is essential for optimizing care.

Purpose of the Study:

  • To explore the experiences of children undergoing hematopoietic stem cell transplant (HCT) and their caregivers.
  • To identify factors influencing adherence to post-discharge medical advice and treatment plans.
  • To gather insights for developing improved, patient-centered adherence strategies.

Main Methods:

  • Qualitative study employing semi-structured interviews with 14 caregivers and 15 pediatric HCT patients.
  • Participants were recruited from a large Midwestern children's hospital.
  • Interviews focused on medication adherence and compliance with post-transplant guidelines.

Main Results:

  • Two primary themes emerged: family navigation of post-HCT care and advice for managing treatment.
  • Structured routines, adaptations to daily life, and managing restrictions were key aspects of self-management.
  • Children increasingly took responsibility for their own medication adherence as they aged.

Conclusions:

  • Pediatric HCT adherence requires interventions beyond traditional medical approaches.
  • Tailored, family-centered strategies and clear communication are vital for improving patient outcomes.
  • Healthcare providers should integrate psychosocial considerations into HCT care plans.
Abstract

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.1K
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
547
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.3K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
678
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
369